AU3735900A - Methods of treatment and prevention of restenosis - Google Patents
Methods of treatment and prevention of restenosisInfo
- Publication number
- AU3735900A AU3735900A AU37359/00A AU3735900A AU3735900A AU 3735900 A AU3735900 A AU 3735900A AU 37359/00 A AU37359/00 A AU 37359/00A AU 3735900 A AU3735900 A AU 3735900A AU 3735900 A AU3735900 A AU 3735900A
- Authority
- AU
- Australia
- Prior art keywords
- restenosis
- prevention
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26642499A | 1999-03-11 | 1999-03-11 | |
US09266424 | 1999-03-11 | ||
PCT/US2000/006279 WO2000053210A1 (en) | 1999-03-11 | 2000-03-13 | Methods of treatment and prevention of restenosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3735900A true AU3735900A (en) | 2000-09-28 |
Family
ID=23014538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU37359/00A Abandoned AU3735900A (en) | 1999-03-11 | 2000-03-13 | Methods of treatment and prevention of restenosis |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3735900A (en) |
WO (1) | WO2000053210A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
US20170008975A1 (en) * | 2014-01-28 | 2017-01-12 | Lankenau Institute For Medical Research | Anti-Tissue Inhibitor of Metalloproteinase-4 (Timp-4) Antibodies and Methods of Use Thereof |
WO2016208880A1 (en) * | 2015-06-26 | 2016-12-29 | 주식회사 파마리서치프로덕트 | Composition for preventing or treating ischemic enteritis containing dna fragment mixture isolated from sperm or testis of fish |
KR20170001567A (en) | 2015-06-26 | 2017-01-04 | 주식회사 파마리서치프로덕트 | Composition comprising mixture of DNA fragments separated from fish's semen or testis for the prevention or treatment of ischemic colitis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE354638T1 (en) * | 1994-12-13 | 2007-03-15 | Human Genome Sciences Inc | HUMAN TISSUE INHIBITOR OF METALLOPROTEINASE-4 |
US5643752A (en) * | 1996-01-18 | 1997-07-01 | Incyte Pharmaceuticals, Inc. | Tissue inhibitor of metalloproteinases |
-
2000
- 2000-03-13 WO PCT/US2000/006279 patent/WO2000053210A1/en active Application Filing
- 2000-03-13 AU AU37359/00A patent/AU3735900A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000053210A1 (en) | 2000-09-14 |
WO2000053210A9 (en) | 2002-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
AU5056300A (en) | Devices and compounds for treating arterial restenosis | |
AU2495200A (en) | Compositions and methods for the treatment of tumor | |
AU9016898A (en) | Methods and compositions for treatment of restenosis | |
AU6435398A (en) | Prevention and treatment of hepatocellular cancer | |
AU5908300A (en) | Prevention and treatment of amyloid-associated disorders | |
AU2476200A (en) | Ribozyme therapy for the treatment and/or prevention of restenosis | |
AU1556497A (en) | Agents for the treatment and prevention of aids | |
AU2002359747A1 (en) | Prevention and treatment of atherosclerosis and restenosis | |
AU8037900A (en) | Modular processing devices and methods of use | |
AU1794801A (en) | Method for treatment and prevention of physiological shock | |
AU7601400A (en) | Treatment and prevention of hepatic disorders | |
AU3270301A (en) | Combined pde3 and pde4 inhibitor therapy for the treatment of obesity | |
AU2964199A (en) | Prevention and treatment of adhesions | |
AU3735900A (en) | Methods of treatment and prevention of restenosis | |
AU2566201A (en) | Compounds and methods for the treatment of pain | |
AU2002222125A1 (en) | Prevention and treatment of tachyphylactic response | |
AU5552400A (en) | Treatment of cancer | |
AUPQ367699A0 (en) | Treatment of cancer | |
AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU1392601A (en) | Prevention and treatment of biomaterial-associated infections | |
AU4598400A (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |